Hodgkin Lymphoma: Leah’s Story - Johns Hopkins Medicine
Hodgkin Lymphoma: Leah’s Story Johns Hopkins Medicine
Hodgkin Lymphoma News
Estrella Immunopharma Activates Intermountain Health LDS Hospital as Fifth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma - BioSpace
Estrella Immunopharma Activates Intermountain Health LDS Hospital as Fifth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma BioSpace
Post-Treatment Fertility in Hodgkin Lymphoma - Hematology Advisor
Post-Treatment Fertility in Hodgkin Lymphoma Hematology Advisor
After Treatment: A Hodgkin Lymphoma Survivor Talks about What Happens in Remission - Pfizer
After Treatment: A Hodgkin Lymphoma Survivor Talks about What Happens in Remission Pfizer
Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up - Wiley Online Library
Hodgkin lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow-up Wiley Online Library
Understanding Hodgkin lymphoma cell origins could yield better diagnostics - Cornell Chronicle
Understanding Hodgkin lymphoma cell origins could yield better diagnostics Cornell Chronicle
Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein response | Blood Cancer Journal - Nature
Transcriptome sequencing of Hodgkin lymphoma Hodgkin and Reed-Sternberg cells reveals escape from NK cell recognition and an unfolded protein response | Blood Cancer Journal Nature
Long-Term Survivors of Hodgkin Lymphoma May Face Elevated Health Risks, Study Finds - The ASCO Post
Long-Term Survivors of Hodgkin Lymphoma May Face Elevated Health Risks, Study Finds The ASCO Post
Clarkston twins beat Hodgkin’s lymphoma, head off to college - ClickOnDetroit | WDIV Local 4
Clarkston twins beat Hodgkin’s lymphoma, head off to college ClickOnDetroit | WDIV Local 4
Hodgkin lymphoma survivors face twice the risk of death compared to average American adult - UT MD Anderson
Hodgkin lymphoma survivors face twice the risk of death compared to average American adult UT MD Anderson
Camp Lejeune Lawsuit News and Updates - Lawsuit Information Center
Camp Lejeune Lawsuit News and Updates Lawsuit Information Center
Brown-Shuler to Undergo Treatment for Hodgkin Lymphoma - Clemson University Athletics
Brown-Shuler to Undergo Treatment for Hodgkin Lymphoma Clemson University Athletics
Pembrolizumab Combo Shows Efficacy in Pediatric High-Risk Hodgkin Lymphoma - CancerNetwork
Pembrolizumab Combo Shows Efficacy in Pediatric High-Risk Hodgkin Lymphoma CancerNetwork
Primary classical Hodgkin lymphoma of breast presenting as recurrent breast abscess in a non-lactating woman: a case report and literature review - Frontiers
Primary classical Hodgkin lymphoma of breast presenting as recurrent breast abscess in a non-lactating woman: a case report and literature review Frontiers
Outcomes of patients with relapsed or refractory classic Hodgkin lymphoma after frontline brentuximab vedotin - Nature
Outcomes of patients with relapsed or refractory classic Hodgkin lymphoma after frontline brentuximab vedotin Nature
Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure” - Frontiers
Evolution of therapeutic paradigms in Hodgkin lymphoma: from “cure-oriented” to “functional cure” Frontiers
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial - Nature
Englumafusp alfa plus glofitamab in B cell non-Hodgkin lymphoma: a phase 1 trial Nature
Hodgkin lymphoma transformation in patients with chemotherapy-naïve chronic lymphocytic leukemia - Nature
Hodgkin lymphoma transformation in patients with chemotherapy-naïve chronic lymphocytic leukemia Nature
Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma: a pooled analysis of four prospective cohorts - Nature
Epstein-Barr virus antibodies and risk of non-Hodgkin lymphoma: a pooled analysis of four prospective cohorts Nature
Prevalence, pattern and prognosis of lung lesions in pediatric Hodgkin lymphoma - Nature
Prevalence, pattern and prognosis of lung lesions in pediatric Hodgkin lymphoma Nature
AZD3470 Displays Clinical Activity in Pretreated Classic Hodgkin Lymphoma - CancerNetwork
AZD3470 Displays Clinical Activity in Pretreated Classic Hodgkin Lymphoma CancerNetwork
Nivolumab/AVD: A New Standard in Untreated Advanced Hodgkin Lymphoma - CancerNetwork
Nivolumab/AVD: A New Standard in Untreated Advanced Hodgkin Lymphoma CancerNetwork
Long-Term Hodgkin Lymphoma Survivors Show Nearly 2-Fold Mortality Increase - CancerNetwork
Long-Term Hodgkin Lymphoma Survivors Show Nearly 2-Fold Mortality Increase CancerNetwork
Hodgkin vs. Non-Hodgkin Lymphoma: How To Tell the Difference - Health.com
Hodgkin vs. Non-Hodgkin Lymphoma: How To Tell the Difference Health.com
Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors - Nature
Genome-scale spatial mapping of the Hodgkin lymphoma microenvironment identifies tumor cell survival factors Nature
Outlining Common Drawbacks to Prior Standards for Hodgkin Lymphoma - CancerNetwork
Outlining Common Drawbacks to Prior Standards for Hodgkin Lymphoma CancerNetwork
PET-Guided Nivolumab Yields High Responses in Hodgkin Lymphoma - OncLive
PET-Guided Nivolumab Yields High Responses in Hodgkin Lymphoma OncLive
Targeting CAR-T cell exhaustion in non-Hodgkin lymphoma: mechanistic insights and emerging clinical strategies - Frontiers
Targeting CAR-T cell exhaustion in non-Hodgkin lymphoma: mechanistic insights and emerging clinical strategies Frontiers
Maesteg teen whose cancer returned after remission has clinical trial hope - BBC
Maesteg teen whose cancer returned after remission has clinical trial hope BBC
Radiotherapy for R/R Hodgkin Lymphoma: Targeting Residual Disease After BV and PD-1 Blockade - Oncodaily
Radiotherapy for R/R Hodgkin Lymphoma: Targeting Residual Disease After BV and PD-1 Blockade Oncodaily
AZD3470 at ASCO 2026: a promising new drug for Hodgkin lymphoma? - Clinical Trials Arena
AZD3470 at ASCO 2026: a promising new drug for Hodgkin lymphoma? Clinical Trials Arena
FDA Approves Nivolumab Plus AVD for Untreated Classical Hodgkin Lymphoma - OncLive
FDA Approves Nivolumab Plus AVD for Untreated Classical Hodgkin Lymphoma OncLive
New treatment combination offers excellent results for early-stage Hodgkin lymphoma with less chemotherapy - UT MD Anderson
New treatment combination offers excellent results for early-stage Hodgkin lymphoma with less chemotherapy UT MD Anderson
Novel combination therapy yields high response rates in early-stage classical Hodgkin lymphoma - UT MD Anderson
Novel combination therapy yields high response rates in early-stage classical Hodgkin lymphoma UT MD Anderson
Intermittent Hypothermia in Hodgkin’s Lymphoma: A Potential Indicator for Urgent Chemotherapy Initiation - Wiley Online Library
Intermittent Hypothermia in Hodgkin’s Lymphoma: A Potential Indicator for Urgent Chemotherapy Initiation Wiley Online Library
CD20-Positive B-Cell Non-Hodgkin Lymphoma Associated With Recurrent Acute Pancreatitis, Bilateral Renal Lesions, and Retroperitoneal Lymphadenopathy - Cureus
CD20-Positive B-Cell Non-Hodgkin Lymphoma Associated With Recurrent Acute Pancreatitis, Bilateral Renal Lesions, and Retroperitoneal Lymphadenopathy Cureus
Evaluation of incidence and outcomes of transformed nodular lymphocyte predominant Hodgkin Lymphoma in the United States: a population-based cohort study - Nature
Evaluation of incidence and outcomes of transformed nodular lymphocyte predominant Hodgkin Lymphoma in the United States: a population-based cohort study Nature
Hodgkin Lymphoma Develops as a Result of Arrested B Cell–Plasma Cell Transition - Inside Precision Medicine
Hodgkin Lymphoma Develops as a Result of Arrested B Cell–Plasma Cell Transition Inside Precision Medicine
Clinical psychologist: A Hodgkin lymphoma diagnosis as a young adult changed my life - UT MD Anderson
Clinical psychologist: A Hodgkin lymphoma diagnosis as a young adult changed my life UT MD Anderson
Nodular lymphocyte-predominant Hodgkin lymphoma: Leah's story - Roswell Park Comprehensive Cancer Center
Nodular lymphocyte-predominant Hodgkin lymphoma: Leah's story Roswell Park Comprehensive Cancer Center